Reduction of chromogranin A and B but not C in the cerebrospinal fluid in subjects with schizophrenia (Q48151640)

9 February 2018

title

Reduction of chromogranin A and B but not C in the cerebrospinal fluid in subjects with schizophrenia (English)

1 reference

9 February 2018

0 references

0 references

1 reference

9 February 2018

Kaj Blennow

object named as

Blennow K

1 reference

9 February 2018

Carl-Gerhard Gottfries

object named as

Gottfries CG

1 reference

9 February 2018

author name string

Grenfeldt B

1 reference

9 February 2018

Davidsson P

1 reference

9 February 2018

Stridsberg M

1 reference

9 February 2018

Regland B

1 reference

9 February 2018

language of work or name

English

0 references

publication date

1 June 1999

1 reference

9 February 2018

European Neuropsychopharmacology

published in

1 reference

9 February 2018

volume

1 reference

9 February 2018

issue

1 reference

9 February 2018

page(s)

311-315

1 reference

9 February 2018

Recent advances in defining the neuropathology of schizophrenia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900042-X

7 January 2021

Neurobiological investigations in cingulate cortex of schizophrenic brain

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900042-X

7 January 2021

Synaptic degeneration in thalamus in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900042-X

7 January 2021

Excess mortality of schizophrenia. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900042-X

7 January 2021

Chromogranin A applied to the nucleus accumbens decreases locomotor activity induced by activation of the mesolimbic dopaminergic system in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900042-X

7 January 2021

Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900042-X

7 January 2021

Chromogranins A, B, and C: widespread constituents of secretory vesicles

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900042-X

7 January 2021

Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900042-X

7 January 2021

Molecular characterization of immunoreactivities of peptides derived from chromogranin A (GE-25) and from secretogranin II (secretoneurin) in human and bovine cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900042-X

7 January 2021

Costs of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900042-X

7 January 2021

CSF of neuroleptic-naive first-episode schizophrenic patients: levels of biogenic amines, substance P, and peptides derived from chromogranin A (GE-25) and secretogranin II (secretoneurin)

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900042-X

7 January 2021

Chromogranin A-like immunoreactivity in the human brain: distribution in bulbar medulla and cerebral cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900042-X

7 January 2021

Chromogranin A immunoreactivity in human cerebrospinal fluid: properties, relationship to noradrenergic neuronal activity, and variation in neurologic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900042-X

7 January 2021

The granin family--its role in sorting and secretory granule formation

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900042-X

7 January 2021

Regional distribution of chromogranin B 420-493-like immunoreactivity in the pituitary gland and central nervous system of man, guinea-pig and rat

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900042-X

7 January 2021

Decreased regional cortical gray matter volume in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900042-X

7 January 2021

Chromogranin immunoreactivity in the central nervous system. Immunochemical characterisation, distribution and relationship to catecholamine and enkephalin pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900042-X

7 January 2021

Chromogranin A and chromogranin B are sensitive circulating markers for phaeochromocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900042-X

7 January 2021

Fragments of chromogranin A are present in the urine of patients with carcinoid tumours: development of a specific radioimmunoassay for chromogranin A and its fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900042-X

7 January 2021

Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900042-X

7 January 2021

Chromogranin A triggers a phenotypic transformation and the generation of nitric oxide in brain microglial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900042-X

7 January 2021

CSF chromogranin A-like immunoreactivity in schizophrenia. Assessment of clinical and biochemical relationships

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900042-X

7 January 2021

CSF chromogranin A-like immunoreactivity in schizophrenia: Relationships with REM latency and slow wave sleep

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900042-X

7 January 2021

From neuropathology to neurodevelopment

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900042-X

7 January 2021

Expression of chromogranin A in lesions in the central nervous system from patients with neurological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900042-X

7 January 2021

Widespread cerebral gray matter volume deficits in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2898%2900042-X

7 January 2021

10.1016/S0924-977X(98)00042-X

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018